UA103779C2 - Ветеринарная антипролактиновая композиция для жвачных - Google Patents
Ветеринарная антипролактиновая композиция для жвачныхInfo
- Publication number
- UA103779C2 UA103779C2 UAA201105713A UAA201105713A UA103779C2 UA 103779 C2 UA103779 C2 UA 103779C2 UA A201105713 A UAA201105713 A UA A201105713A UA A201105713 A UAA201105713 A UA A201105713A UA 103779 C2 UA103779 C2 UA 103779C2
- Authority
- UA
- Ukraine
- Prior art keywords
- ruminants
- antiprolactinic
- veterinary composition
- antiprolactinic veterinary
- composition
- Prior art date
Links
- 241000282849 Ruminantia Species 0.000 title abstract 3
- 102000015554 Dopamine receptor Human genes 0.000 abstract 1
- 108050004812 Dopamine receptor Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000006651 lactation Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0805544A FR2936710B1 (fr) | 2008-10-07 | 2008-10-07 | Composition veterinaire antiprolactinique destinee aux ruminants |
| PCT/EP2009/063004 WO2010040765A1 (fr) | 2008-10-07 | 2009-10-07 | Composition veterinaire antiprolactinique destinee aux ruminants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA103779C2 true UA103779C2 (ru) | 2013-11-25 |
Family
ID=40527505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201105713A UA103779C2 (ru) | 2008-10-07 | 2009-10-07 | Ветеринарная антипролактиновая композиция для жвачных |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9730923B2 (https=) |
| EP (1) | EP2349272B1 (https=) |
| JP (1) | JP5955561B2 (https=) |
| KR (2) | KR101892559B1 (https=) |
| CN (1) | CN102215843B (https=) |
| AU (1) | AU2009301134B2 (https=) |
| BR (1) | BRPI0914064A2 (https=) |
| CA (1) | CA2738875C (https=) |
| DK (1) | DK2349272T3 (https=) |
| ES (1) | ES2719844T3 (https=) |
| FR (1) | FR2936710B1 (https=) |
| HU (2) | HUE043239T2 (https=) |
| IL (1) | IL212125B (https=) |
| MA (1) | MA32763B1 (https=) |
| MX (1) | MX2011003743A (https=) |
| NO (1) | NO2019028I1 (https=) |
| NZ (1) | NZ592288A (https=) |
| PL (1) | PL2349272T3 (https=) |
| PT (1) | PT2349272T (https=) |
| RU (1) | RU2528892C2 (https=) |
| SI (1) | SI2349272T1 (https=) |
| UA (1) | UA103779C2 (https=) |
| WO (1) | WO2010040765A1 (https=) |
| ZA (1) | ZA201103273B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2971423B1 (fr) | 2011-02-15 | 2014-01-10 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
| EP2995297A1 (fr) * | 2014-09-09 | 2016-03-16 | Ceva Sante Animale | Compositions parentérales et leurs utilisations |
| US20200071408A1 (en) | 2016-11-29 | 2020-03-05 | National Center Of Neurology And Psychiatry | Prophylactic agent, onset-suppressing agent or therapeutic agent for progressive immune demyelinating diseases |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| KR20220009954A (ko) | 2019-04-17 | 2022-01-25 | 컴퍼스 패쓰파인더 리미티드 | 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법 |
| EP4064854A1 (en) | 2019-11-28 | 2022-10-05 | Boehringer Ingelheim Vetmedica GmbH | Use of sglt-2 inhibitors in the drying-off of non-human mammals |
| UY39022A (es) * | 2020-01-27 | 2021-07-30 | Ceva Sante Animale | Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria |
| AR122366A1 (es) * | 2020-01-27 | 2022-09-07 | Ceva Sante Animale | Composición veterinaria para rumiantes lecheros para el tratamiento de la fiebre de la leche |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839171A (en) * | 1984-11-30 | 1989-06-13 | Techmix, Inc. | Composition for treating impaired lactation |
| US4939259A (en) * | 1989-07-24 | 1990-07-03 | Eli Lilly And Company | 2-oxo-pyrido[2,3-g]quinoline derivatives |
| WO2000054776A1 (en) * | 1999-03-17 | 2000-09-21 | Eugen Eigenmann | Use of prolactin inhibitors for the treatment of fertility problems in animal species |
| GB0108485D0 (en) * | 2001-04-04 | 2001-05-23 | Pfizer Ltd | Combination therapy |
| NZ515178A (en) * | 2001-11-23 | 2004-09-24 | Agres Ltd | Modulating prolactin receptors to affect a physiological response |
| GB0313892D0 (en) * | 2003-06-16 | 2003-07-23 | Hannah Res Inst | Control of lactation |
| GB0314469D0 (en) | 2003-06-20 | 2003-07-23 | Phico Therapeutics Ltd | Antimicrobial compositions and uses thereof |
| CN1762495B (zh) * | 2004-09-21 | 2011-04-06 | 山东绿叶制药有限公司 | 含有多巴胺受体激动剂类药物的长效缓释制剂及其制备工艺 |
| KR20070059161A (ko) * | 2004-09-21 | 2007-06-11 | 산동 루예 파마슈티칼 컴파니 리미티드 | 도파민 수용체 효능제를 함유하는 장시간 작용 서방성 제제및 그 제조방법 |
| EP1952813A1 (en) * | 2007-02-01 | 2008-08-06 | Ferring International Center S.A. | Medicament for the treatment of endometriosis |
| ITTO20070479A1 (it) * | 2007-07-02 | 2009-01-03 | Ceva Vetem S P A | Composizione veterinaria iniettabile ad attivita' anti-prolattinica |
-
2008
- 2008-10-07 FR FR0805544A patent/FR2936710B1/fr active Active
-
2009
- 2009-10-07 PL PL09783801T patent/PL2349272T3/pl unknown
- 2009-10-07 WO PCT/EP2009/063004 patent/WO2010040765A1/fr not_active Ceased
- 2009-10-07 PT PT09783801T patent/PT2349272T/pt unknown
- 2009-10-07 KR KR1020177002975A patent/KR101892559B1/ko active Active
- 2009-10-07 UA UAA201105713A patent/UA103779C2/ru unknown
- 2009-10-07 HU HUE09783801A patent/HUE043239T2/hu unknown
- 2009-10-07 AU AU2009301134A patent/AU2009301134B2/en active Active
- 2009-10-07 DK DK09783801.5T patent/DK2349272T3/da active
- 2009-10-07 BR BRPI0914064A patent/BRPI0914064A2/pt not_active Application Discontinuation
- 2009-10-07 JP JP2011530475A patent/JP5955561B2/ja active Active
- 2009-10-07 MX MX2011003743A patent/MX2011003743A/es active IP Right Grant
- 2009-10-07 SI SI200931957T patent/SI2349272T1/sl unknown
- 2009-10-07 NZ NZ592288A patent/NZ592288A/xx unknown
- 2009-10-07 EP EP09783801.5A patent/EP2349272B1/fr active Active
- 2009-10-07 KR KR1020117009774A patent/KR20110110091A/ko not_active Ceased
- 2009-10-07 ES ES09783801T patent/ES2719844T3/es active Active
- 2009-10-07 CA CA2738875A patent/CA2738875C/fr active Active
- 2009-10-07 RU RU2011118366/15A patent/RU2528892C2/ru active
- 2009-10-07 CN CN200980145820.7A patent/CN102215843B/zh active Active
-
2011
- 2011-04-04 IL IL212125A patent/IL212125B/en active IP Right Grant
- 2011-04-07 US US13/081,671 patent/US9730923B2/en active Active
- 2011-05-02 MA MA33803A patent/MA32763B1/fr unknown
- 2011-05-05 ZA ZA2011/03273A patent/ZA201103273B/en unknown
-
2013
- 2013-03-14 US US13/828,023 patent/US9744158B2/en active Active
-
2019
- 2019-07-05 NO NO2019028C patent/NO2019028I1/no unknown
- 2019-07-08 HU HUS1900036C patent/HUS1900036I1/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA103779C2 (ru) | Ветеринарная антипролактиновая композиция для жвачных | |
| UA104129C2 (ru) | Уменьшение сопутствующих инфекций у свиней с помощью антигена pcv2 | |
| WO2012012498A3 (en) | Use of trp channel agonists to treat infections | |
| DK201470535A (en) | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof | |
| MX340489B (es) | Combinaciones que comprenden antipsicoticos atipicos y agonistas de receptor 1 asociado a aminas traza (taar1). | |
| MX2011008450A (es) | Agonistas y antagonistas del receptor s1p5, y metodos de uso de los mismos. | |
| MX2009011862A (es) | Composiciones farmaceuticas de administracion oronasofaringea de agonistas de la dopamina para la prevencion/alivio y/o tratamiento del desorden de miembros inquietos. | |
| BRPI0507279A (pt) | método e dispositivo para o tratamento do canal da teta de um animal | |
| MX2021001169A (es) | Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas. | |
| NZ710757A (en) | Methods of treating microbial infections, including mastitis | |
| NZ706990A (en) | A veterinary method of alleviating noise aversion | |
| PH12015502282A1 (en) | Alpha-2 adrenoceptor and sigma receptor ligand combinations | |
| BR112013010136A2 (pt) | vacina, composição terapêutica e métodos para o tratamento ou inibição de gliblastoma | |
| NZ702415A (en) | Methods for treating neutropenia using retinoid agonists | |
| FR2971423B1 (fr) | Composition veterinaire antiprolactinique destinee aux ruminants | |
| MX2018008856A (es) | Composiciones para mejorar el uso de nitrogeno en un rumiante. | |
| BR112012018154A2 (pt) | agonista alfa-2 adrenérgico tendo longa duração do efeito de redução da pressão intraocular | |
| BR122020011180B8 (pt) | formulações injetáveis de compostos de tetraciclina | |
| PH12013500371A1 (en) | Therapeutic agent for pain | |
| MX2013013182A (es) | Tratamiento de la mastitis. | |
| BR112012033121A2 (pt) | métodos e composições farmacêuticas para o tratamento de infecções do trato respiratório. | |
| AU2014360618A1 (en) | Method for preparing an anthelmintic composition, anthelmintic composition, veterinary treatment method and anthelmintic treatment method | |
| MX2016005092A (es) | Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos. | |
| MX2014004743A (es) | Uso de derivados de aminoacetonitrilo contra endoparasitos. | |
| WO2014153505A3 (en) | Treatment of chemotherapy-induced peripheral neuropathy |